| abstract |
As used herein, combinations of antigen-binding proteins that bind to BCMA and antigen-binding proteins that bind to immunomodulators such as PD-1 or OX40, their pharmaceutical compositions, their use, and their use in cancer. Disclosed are therapeutic methods comprising administering the above combinations, including: |